AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erasmus, J. J.
Right arrow Articles by Goodman, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erasmus, J. J.
Right arrow Articles by Goodman, P. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 168, 1357-1360, Copyright © 1997 by American Roentgen Ray Society

ARTICLES

Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography

JJ Erasmus, EF Patz Jr, HP McAdams, JG Murray, J Herndon, RE Coleman and PC Goodman
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.

OBJECTIVE: The purpose of this study was to assess the usefulness of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) when differentiating benign from metastatic adrenal masses in patients with bronchogenic carcinoma. SUBJECTS AND METHODS: For our prospective study, any patient presenting to our institution with pathologically proven bronchogenic carcinoma and an adrenal mass was eligible. Thirty- three adrenal masses (mean size, 3 cm; range, 1-9 cm) in 27 patients were revealed by CT. PET was performed in all 27 patients and interpreted as positive when FDG uptake in the adrenal mass was greater than background activity or negative when FDG uptake in the adrenal mass was equal to or less than background activity. In addition, semiquantitative analysis was performed by computing a standardized uptake ratio. All studies were reviewed independently by three radiologists and then correlated with biopsy and CT findings. Specificity and sensitivity for determining metastatic disease to the adrenal gland were calculated. RESULTS: FDG uptake was positive (abnormally increased) in 25 adrenal masses. Twenty-three (92%) of the 25 masses were metastatic disease. The mean standardized uptake ratio of these was 6.28 (range, 3.22-14.41). The remaining two masses (8%) that had positive FDG uptake showed no tumor at percutaneous biopsy. The standardized uptake ratio values for these two masses were 3.0 and 3.7. FDG uptake was negative (normal) in eight adrenal masses. All these lesions were benign as proven by biopsy (n = 2) and CT attenuation values of less than 10 H (n = 6). The mean standardized uptake ratio value for these eight lesions classified as benign was 1.77 (range, 0.93-3.70). The sensitivity for detecting metastatic disease was 100%, and the specificity was 80%. CONCLUSION: PET with FDG is an accurate, noninvasive way to differentiate benign from metastatic adrenal masses in patients with bronchogenic carcinoma.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
Y. C. Ung, D. E. Maziak, J. A. Vanderveen, C. A. Smith, K. Gulenchyn, C. Lacchetti, W. K. Evans, and Lung Cancer Disease Site Group of Cancer Care Onta
18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
J Natl Cancer Inst, December 5, 2007; 99(23): 1753 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 178S - 201S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Singh, B. Camazine, Y. Jadhav, R. Gupta, P. Mukhopadhyay, A. Khan, R. Reddy, Q. Zheng, D. D. Smith, R. Khode, et al.
Endoscopic Ultrasound As a First Test for Diagnosis and Staging of Lung Cancer: A Prospective Study
Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 345 - 354.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
I. C. Mitchell and F. E. Nwariaku
Adrenal Masses in the Cancer Patient: Surveillance or Excision
Oncologist, February 1, 2007; 12(2): 168 - 174.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
S. Chong, K. S. Lee, H. Y. Kim, Y. K. Kim, B.-T. Kim, M. J. Chung, C. A Yi, and G. Y. Kwon
Integrated PET-CT for the Characterization of Adrenal Gland Lesions in Cancer Patients: Diagnostic Efficacy and Interpretation Pitfalls
RadioGraphics, November 1, 2006; 26(6): 1811 - 1824.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller
Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT
RadioGraphics, September 1, 2006; 26(5): 1335 - 1353.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. C. Mackie, B. L. Shulkin, R. C. Ribeiro, F. P. Worden, P. G. Gauger, R. J. Mody, L. P. Connolly, G. Kunter, C. Rodriguez-Galindo, J. W. Wallis, et al.
Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2665 - 2671.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Bunyaviroch and R. E. Coleman
PET Evaluation of Lung Cancer
J. Nucl. Med., March 1, 2006; 47(3): 451 - 469.
[Full Text] [PDF]

Home page
 RadiologyHome page
M. A. Blake, J. M. A. Slattery, M. K. Kalra, E. F. Halpern, A. J. Fischman, P. R. Mueller, and G. W. Boland
Adrenal Lesions: Characterization with Fused PET/CT Image in Patients with Proved or Suspected Malignancy--Initial Experience
Radiology, March 1, 2006; 238(3): 970 - 977.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
U. Metser, E. Miller, H. Lerman, G. Lievshitz, S. Avital, and E. Even-Sapir
18F-FDG PET/CT in the Evaluation of Adrenal Masses
J. Nucl. Med., January 1, 2006; 47(1): 32 - 37.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. B. Costa, J. A. Parker, and S. T. Schumer
Modern Treatment of Lung Cancer: CASE 3. Non-Metastatic Bilateral F-18 Fluorodeoxyglucose Avid Adrenal Glands in Non-Small-Cell Lung Cancer
J. Clin. Oncol., October 20, 2005; 23(30): 7740 - 7742.
[Full Text] [PDF]

Home page
 JCOHome page
D. Lardinois, W. Weder, M. Roudas, G. K. von Schulthess, M. Tutic, H. Moch, R. A. Stahel, and H. C. Steinert
Etiology of Solitary Extrapulmonary Positron Emission Tomography and Computed Tomography Findings in Patients With Lung Cancer
J. Clin. Oncol., October 1, 2005; 23(28): 6846 - 6853.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O. Birim, A. P. Kappetein, T. Stijnen, and A. J.J.C. Bogers
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer
Ann. Thorac. Surg., January 1, 2005; 79(1): 375 - 382.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. Kumar, Y. Xiu, J. Q. Yu, A. Takalkar, G. El-Haddad, S. Potenta, J. Kung, H. Zhuang, and A. Alavi
18F-FDG PET in Evaluation of Adrenal Lesions in Patients with Lung Cancer
J. Nucl. Med., December 1, 2004; 45(12): 2058 - 2062.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Oncologist, November 1, 2004; 9(6): 633 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Pacak, G. Eisenhofer, and D. S. Goldstein
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
Endocr. Rev., August 1, 2004; 25(4): 568 - 580.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. C. Detterbeck, S. Falen, M. P. Rivera, J. S. Halle, and M. A. Socinski
Seeking a Home for a PET, Part 2: Defining the Appropriate Place for Positron Emission Tomography Imaging in the Staging of Patients With Suspected Lung Cancer
Chest, June 1, 2004; 125(6): 2300 - 2308.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. M. Rohren, T. G. Turkington, and R. E. Coleman
Clinical Applications of PET in Oncology
Radiology, May 1, 2004; 231(2): 305 - 332.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
Endocr. Rev., April 1, 2004; 25(2): 309 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. D. Paulsen, H. V. Nghiem, M. Korobkin, E. M. Caoili, and E. J. Higgins
Changing Role of Imaging-Guided Percutaneous Biopsy of Adrenal Masses: Evaluation of 50 Adrenal Biopsies
Am. J. Roentgenol., April 1, 2004; 182(4): 1033 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al.
American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. L. Port, M. S. Kent, R. J. Korst, R. Keresztes, M. A. Levin, and N. K. Altorki
Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer
Ann. Thorac. Surg., January 1, 2004; 77(1): 254 - 259.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
C. E. Reed, D. H. Harpole, K. E. Posther, S. L. Woolson, R. J. Downey, B. F. Meyers, R. T. Heelan, H. A. MacApinlac, S.-H. Jung, G. A. Silvestri, et al.
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1943 - 1951.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. J. Cerfolio, B. Ojha, A. S. Bryant, C. S. Bass, A. A. Bartalucci, and J. M. Mountz
The role of FDG-PET scan in staging patients with nonsmall cell carcinoma
Ann. Thorac. Surg., September 1, 2003; 76(3): 861 - 866.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. P. Mac Manus, R. J. Hicks, J. P. Matthews, A. McKenzie, D. Rischin, E. K. Salminen, and D. L. Ball
Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non-Small-Cell Lung Cancer
J. Clin. Oncol., April 1, 2003; 21(7): 1285 - 1292.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and J. C. Porter
Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N. Hollings and P. Shaw
Diagnostic imaging of lung cancer
Eur. Respir. J., April 1, 2002; 19(4): 722 - 742.
[Abstract] [Full Text] [PDF]

Home page
 J. Nucl. Med. Technol.Home page
H. A. Nabi and J. M. Zubeldia
Clinical Applications of 18F-FDG in Oncology
J. Nucl. Med. Technol., March 1, 2002; 30(1): 3 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Yun, W. Kim, N. Alnafisi, L. Lacorte, S. Jang, and A. Alavi
18F-FDG PET in Characterizing Adrenal Lesions Detected on CT or MRI
J. Nucl. Med., December 1, 2001; 42(12): 1795 - 1799.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. J. Hicks, V. Kalff, M. P. MacManus, R. E. Ware, A. Hogg, A. F. McKenzie, J. P. Matthews, and D. L. Ball
18F-FDG PET Provides High-Impact and Powerful Prognostic Stratification in Staging Newly Diagnosed Non-Small Cell Lung Cancer
J. Nucl. Med., November 1, 2001; 42(11): 1596 - 1604.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
R. Komaki, M. H. Chasen, W. D. Travis, J. B. Putnam, F. V. Fossella, R. W. Byhardt, and J. Y. Ro
Oncodiagnosis Panel: 1999: Cancer of the Lung: Oncodiagnosis
RadioGraphics, November 1, 2001; 21(6): 1573 - 1596.
[Full Text] [PDF]

Home page
 RadioGraphicsHome page
W. W. Mayo-Smith, G. W. Boland, R. B. Noto, and M. J. Lee
State-of-the-Art Adrenal Imaging
RadioGraphics, July 1, 2001; 21(4): 995 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Maurea, M. Klain, C. Mainolfi, M. Ziviello, and M. Salvatore
The Diagnostic Role of Radionuclide Imaging in Evaluation of Patients with Nonhypersecreting Adrenal Masses
J. Nucl. Med., June 1, 2001; 42(6): 884 - 892.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. A. Lawson
Role of Molecular Imaging in Management of Nonhypersecreting Adrenal Masses
J. Nucl. Med., June 1, 2001; 42(6): 893 - 894.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. J. Erasmus, H. P. McAdams, S. E. Rossi, P. C. Goodman, R. E. Coleman, and E. F. Patz
FDG PET of Pleural Effusions in Patients with Non--Small Cell Lung Cancer
Am. J. Roentgenol., July 1, 2000; 175(1): 245 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
E. M. Remer, N. Obuchowski, J. D. Ellis, T. W. Rice, D. J. Adelstein, and M. E. Baker
Adrenal Mass Evaluation in Patients with Lung Carcinoma: A Cost-Effectiveness Analysis
Am. J. Roentgenol., April 1, 2000; 174(4): 1033 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. M. Marom, H. P. McAdams, J. J. Erasmus, P. C. Goodman, D. K. Culhane, R. E. Coleman, J. E. Herndon, and E. F. Patz Jr
Staging Non-Small Cell Lung Cancer with Whole-Body PET
Radiology, September 1, 1999; 212(3): 803 - 809.
[Abstract] [Full Text]

Home page
 Eur. J. Cardiothorac. Surg.Home page
H. L. Porte, O. J. Ernst, T. Delebecq, D. Metois, L. G. Lemaitre, and A. J. Wurtz
Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?
Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 597 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. Weder, R. A. Schmid, H. Bruchhaus, S. Hillinger, G. K. von Schulthess, and H. C. Steinert
Detection of extrathoracic metastases by positron emission tomography in lung cancer
Ann. Thorac. Surg., September 1, 1998; 66(3): 886 - 893.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
V. J Lowe and K. S Naunheim
Current role of positron emission tomography in thoracic oncology
Thorax, August 1, 1998; 53(8): 703 - 712.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Roentgen Ray Society.